Charles Schwab Investment Management Inc. Reduces Stock Position in Envista Holdings Co. (NYSE:NVST)

Charles Schwab Investment Management Inc. lessened its stake in shares of Envista Holdings Co. (NYSE:NVST - Free Report) by 12.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,138,031 shares of the company's stock after selling 306,382 shares during the period. Charles Schwab Investment Management Inc. owned approximately 1.24% of Envista worth $42,247,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the stock. Mirae Asset Global Investments Co. Ltd. purchased a new position in Envista during the 3rd quarter worth approximately $31,000. GAMMA Investing LLC raised its holdings in shares of Envista by 69.8% during the third quarter. GAMMA Investing LLC now owns 1,766 shares of the company's stock worth $35,000 after purchasing an additional 726 shares during the last quarter. Huntington National Bank lifted its position in Envista by 97.8% during the third quarter. Huntington National Bank now owns 1,919 shares of the company's stock valued at $38,000 after purchasing an additional 949 shares during the period. Blue Trust Inc. boosted its holdings in Envista by 69.7% in the third quarter. Blue Trust Inc. now owns 1,957 shares of the company's stock valued at $39,000 after purchasing an additional 804 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC grew its position in Envista by 50.8% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company's stock worth $43,000 after purchasing an additional 728 shares during the period.

Envista Stock Up 0.1 %

NYSE:NVST traded up $0.02 during midday trading on Monday, hitting $22.31. 1,605,268 shares of the company were exchanged, compared to its average volume of 2,382,641. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. Envista Holdings Co. has a fifty-two week low of $15.15 and a fifty-two week high of $25.64. The company has a market capitalization of $3.84 billion, a PE ratio of -2.88, a price-to-earnings-growth ratio of 3.10 and a beta of 1.30. The company has a fifty day simple moving average of $19.79 and a 200 day simple moving average of $18.28.

Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.09 by $0.03. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The firm had revenue of $601.00 million for the quarter, compared to analyst estimates of $590.34 million. During the same quarter last year, the company posted $0.43 earnings per share. The business's revenue was down 4.8% on a year-over-year basis. As a group, equities analysts anticipate that Envista Holdings Co. will post 0.72 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently commented on NVST. Leerink Partnrs raised Envista from a "strong sell" rating to a "hold" rating in a report on Thursday, October 31st. JPMorgan Chase & Co. lowered shares of Envista from an "overweight" rating to a "neutral" rating and cut their target price for the company from $23.00 to $16.00 in a report on Thursday, August 8th. Needham & Company LLC reissued a "hold" rating on shares of Envista in a report on Thursday, October 31st. Leerink Partners raised shares of Envista from an "underperform" rating to a "market perform" rating and lifted their price objective for the company from $16.00 to $23.00 in a report on Thursday, October 31st. Finally, Robert W. Baird upped their price objective on shares of Envista from $17.00 to $22.00 and gave the stock a "neutral" rating in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $20.71.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.